# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | A 485 | A-485 | Cell Proliferation EC50 | 0.329 | uM | ALA4886662 | uM | Homo sapiens | ||||
2. | Carfilzomib | 2 | IC50 | = | 116.1 | nM | ALA4423860 | 6.93 | nM | Homo sapiens | ||
3. | ALA4460323 | 11h | IC50 | = | 51.7 | nM | ALA4423860 | 7.29 | nM | Homo sapiens | ||
4. | ALA53463 | Adriamycin | IC50 | = | 0.2 | uM | ALA4480834 | 6.70 | nM | Homo sapiens | ||
5. | ALA4589468 | 6 | IC50 | = | 4.6 | uM | ALA4480834 | 5.34 | nM | Homo sapiens | ||
6. | ALA4589097 | 5 | IC50 | = | 4 | uM | ALA4480834 | 5.40 | nM | Homo sapiens | ||
7. | ALA4206850 | 6 | IC50 | = | 2.6 | uM | ALA4480834 | 5.58 | nM | Homo sapiens | ||
8. | Tubastatin A | Tubastatin A | IC50 | = | 15.42 | uM | ALA4842883 | 4.81 | nM | Homo sapiens | ||
9. | ALA4866683 | (+/-)-71 | IC50 | = | 7.61 | uM | ALA4842883 | 5.12 | nM | Homo sapiens | ||
10. | ALA4850731 | 40 | Activity | 0 | ALA4836960 | Dose-Dependent Effect | Homo sapiens | |||||
11. | ALA4850731 | 40 | Activity | 0 | ALA4836959 | Dose-Dependent Effect | Homo sapiens | |||||
12. | ALA4850731 | 40 | Activity | 0 | ALA4836957 | Dose-Dependent Effect | Homo sapiens | |||||
13. | A-1210477 | 30e | Activity | 0 | ALA4836957 | Dose-Dependent Effect | Homo sapiens | |||||
14. | ALA4850731 | 40 | Activity | 0 | ALA4836956 | Dose-Dependent Effect | Homo sapiens | |||||
15. | A-1210477 | 30e | Activity | 0 | ALA4836956 | Dose-Dependent Effect | Homo sapiens | |||||
16. | ALA4848433 | 44 | IC50 | = | 0.49 | uM | ALA4836950 | 6.31 | nM | Homo sapiens | ||
17. | ALA4845828 | 43 | IC50 | = | 1.39 | uM | ALA4836950 | 5.86 | nM | Homo sapiens | ||
18. | ALA4848900 | 42 | IC50 | = | 0.48 | uM | ALA4836950 | 6.32 | nM | Homo sapiens | ||
19. | ALA4872248 | 41 | IC50 | = | 0.39 | uM | ALA4836950 | 6.41 | nM | Homo sapiens | ||
20. | ALA4850731 | 40 | IC50 | = | 0.36 | uM | ALA4836950 | 6.44 | nM | Homo sapiens |